Chonluten (Chonluten (Glu-Asp-Gly Bronchopulmonary Bioregulator))
A short synthetic tripeptide bioregulator from the Khavinson family targeted at bronchopulmonary (lung/airway) and mucosal tissue. Used in the bioregulator community for respiratory resilience and mucosal immune support.
How it works
As a signal peptide (Glu-Asp-Gly), it is proposed to regulate gene expression in respiratory epithelial and mucosal tissue, supporting airway lining integrity, antioxidant defense, and local immune function.
Key facts
- Molecular weight: ~318 Da
- Half-life: Short (peptide)
- Bioavailability: Oral (encapsulated) or subcutaneous
- Storage: Room temperature (capsules) or refrigerate (injectable).
Dosing overview
- Typical dose: ~1-2 capsules/day or short injectable courses
- Frequency: Once daily
- Duration: 10-30 day courses
- Route: Oral capsule or subcutaneous
Protocol notes
- Taken as short repeatable courses (often 10-30 days), a few times per year.
- Oral encapsulated forms are taken once daily, usually on an empty stomach.
- Often used seasonally for respiratory support.
Reported benefits
- Respiratory/airway support
- Mucosal immune support
- Antioxidant support in lung tissue (proposed)
- Short course-based protocol
Possible side effects
- Limited Western clinical data
- Injection site reactions (injectable)
- Unknown long-term effects
Research
- Bronchopulmonary peptide bioregulators (2017): Reported to support respiratory epithelial function and antioxidant defense in regional research studies.
Compare Chonluten
Research and educational reference only. Not medical advice.